AREV Life Sciences Global's quarterly market cap
declined
from Mar. 2023 ($5.88 Mil) to Jun. 2023 ($2.76 Mil) and
declined
from Jun. 2023 ($2.76 Mil) to Sep. 2023 ($0.10 Mil).
AREV Life Sciences Global's annual market cap
increased
from Dec. 2020 ($4.94 Mil) to Dec. 2021 ($7.34 Mil) but then
declined
from Dec. 2021 ($7.34 Mil) to Dec. 2022 ($2.57 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AREV Life Sciences Global's Enterprise Value for Today is $1.06 Mil.
AREV Life Sciences Global Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AREV Life Sciences Global's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, AREV Life Sciences Global's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AREV Life Sciences Global's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AREV Life Sciences Global's Market Cap distribution charts can be found below:
* The bar in red indicates where AREV Life Sciences Global's Market Cap falls into.
AREV Life Sciences Global Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AREV Life Sciences Global (OTCPK:AREVF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AREV Life Sciences Global Market Cap Related Terms
Thank you for viewing the detailed overview of AREV Life Sciences Global's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
AREV Life Sciences Global (AREV Life Sciences Global) Business Description
AREV Life Sciences Global Corp is a fully integrated, early stage life science discovery enterprise dedicated to delivering solutions to public healthcare metrics through innovations and successful collaborations in the life science industry. The Company's focuses on dedication to generate revenue by way of novel therapeutic approaches to human nutrition and malnutrition, pandemic diseases, and neglected chronic co-morbidities.
AREV Life Sciences Global (AREV Life Sciences Global) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AREVF has been successfully added to your 